Siltuximab

Trade Name: 
Sylvant
Manufacturer/Distributor: 
Janssen
www.janssen.ca
1-800-567-3331
Classification: 
Immunosuppressive agent
ATC Class: 
L04AC - Interleukin-6 inhibitor
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2014/12/03
Date Marketed in Canada (yyyy/mm/dd): 
2015/01/02
Presentation: 
Powder for solution: 100 mg/vial. DIN: 02435128
Powder for solution: 400 mg/vial. DIN: 02435136
Comments: 
Indicated for treatment of patients with Castleman's disease who are human immunodeficiency virus (HIV)-negative and human herpes virus-8 (HHV-8)-negative. Castleman's disease is also known as giant lymph node hyperplasia and angiofollicular lymph node hyperplasia.